Lupin Pushes Fed. Circ. To Reconsider Fortamet Injunction
Drugmaker Lupin Ltd. urged the Federal Circuit on Wednesday to reverse a preliminary injunction barring the company from selling its generic version of the diabetes drug Fortamet, saying its previous remand...To view the full article, register now.
Already a subscriber? Click here to view full article